A clinical trial has found that low-dose interleukin-2 is safe and may significantly extend survival in people with motor ...

A clinical trial has found that low-dose interleukin-2 is both safe and effective for use on people with motor neuron disease ...

Omega-3 fatty acids, found in oily fish, nuts, and seeds, may play a crucial role in protecting against motor neurone disease (MND) and frontotemporal dementia (FTD), according to new research. While ...

may play a crucial role in protecting against motor neurone disease (MND) and frontotemporal dementia (FTD), according to new research. While a link between omega-3 consumption and a lower MND ...

The results of the MIROCALS randomized clinical trial have shown that adding low-dose interleukin-2 (IL2LD) to standard ...

ALS is a progressive disease and most people live two to five years after ... and visible cramps or twitching from lower ...

Results of the landmark MIROCALS clinical trial, involving researchers from the University of Sheffield, have revealed new insights into the treatment of motor neuron disease (MND ... the study ...

Over nearly 7 years, the autologous hematopoietic stem-cell-based gene therapy led to lower risk ... presence of motor symptoms at onset is associated with a more severe, rapid disease course.

ALS is a progressive disease and most people live two to ... and visible cramps or twitching from lower motor neuron degeneration Bulbar involvement (caused by damaged nerve cells in part of ...